Influenza A H10N8

In December 2013, the first human case of avian influenza A H10N8 virus infection was reported in China. The second human H10N8 infection was identified in Jiangxi province in January 2014. The third H10N8 patient was from Nanchang who presented with fever and fatigue on 4 February 2014. As the H10N8 virus is a novel influenza strain for humans, the majority of the human population lacks immunity to the virus. Although this virus was hypothesized to be from wild birds and domestic poultry, its evolutionary path leading to human infection is unknown. Thus, if the virus acquired mutations required for sustained person-to-person transmission, it would have the potential to initiate a pandemic.

Reference:
• Yifei Xu. Identification of the source of A (H10N8) virus causing human infection. Infect Genet Evol. 2015
• Kapil Bahl. Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses. Molecular Therapy.2017
• Li-Fang Kuah. Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice. Journal of General Virology.2017

 

Reagents of H10N8 by Influenza Antigens

All Influenza H10N8 Reagents (Proteins | Antibodies | cDNAs | ELISA Kits)

H10N8 Proteins

  • • H10N8 Hemagglutinin / HA protein
  • • H10N8 Neuraminidase / NA protein

H10N8 Antibodies

  • • H10N8 Hemagglutinin / HA antibody
  • • H10N8 Neuraminidase / NA antibody
  • • H10N8 Nucleoprotein / NP antibody

H10N8 cDNAs/Genes

  • • H10N8 Hemagglutinin / HA cDNA

More H10 subtypes of Influenza virus

More N8 subtypes of Influenza virus

 

Strains of Influenza H10N8

Here we list some hot research strains of H10N8.